Showing results (611-620 of 669) with videos related to

Sort By:
Pageof 67
Hemasphere|February 27, 2023
Autoimmune Lymphoproliferative Syndrome (ALPS) Disease and ALPS Phenotype: Are They Two Distinct Entities?Elena Palmisani, Maurizio Miano, Alice Grossi, et al.
Hemasphere|February 6, 2023
Hematopoietic Cell Autonomous Disruption of Hematopoiesis in a Germline Loss-of-function Mouse Model of RUNX1-FPDMartijn P T Ernst, Eline Pronk, Claire van Dijk, et al.
Hemasphere|December 11, 2025
Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early-life DNMT3A mutationsLucca L M Derks, Konradin F Müskens, Markus J van Roosmalen, et al.
Hemasphere|December 10, 2025
Functional differences between CLL- and ALL-derived CAR T cells in a 3D tumor microenvironment highlight CXCR4 and IL-10 as potential modulatory targetsJanin Dingfelder, Michael Aigner, Jana Lindacher, et al.
Hemasphere|July 11, 2020
Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple MyelomaAdrián Alegre, Javier de la Rubia, Anna Sureda Balari, et al.
Hemasphere|May 8, 2023
Impact of Clonal Architecture on Clinical Course and Prognosis in Patients With Myeloproliferative NeoplasmsDamien Luque Paz, Michael S Bader, Ronny Nienhold, et al.
Hemasphere|May 8, 2023
NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple MyelomaChristie P M Verkleij, Kristine A Frerichs, Marloes E C Broekmans, et al.
Hemasphere|May 1, 2023
Risk Factors of Progression in Low-tumor Burden Follicular Lymphoma Initially Managed by Watch and Wait in the Era of PET and RituximabCyrielle Rodier, Lukshe Kanagaratnam, David Morland, et al.
Hemasphere|April 11, 2023
Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHLKai Rejeski, Viktoria Blumenberg, Gloria Iacoboni, et al.
Hemasphere|April 3, 2023
CTP Synthase 1 Is a Novel Therapeutic Target in LymphomaHélène Asnagli, Norbert Minet, Christina Pfeiffer, et al.
Pageof 67